Brief: Stayble Therapeutics Q4 EBIT Loss Widens To SEK 4.6 Million

Stayble Therapeutics AB

22/02/2022 07:11

Feb 22 (Reuters) - Stayble Therapeutics  STABL.ST :
    * Q4 EBIT LOSS SEK 4.6 MILLION VERSUS LOSS 915,000 YEAR AGO
    * Q4 LOSS FOR PERIOD SEK 4.6 MILLION VERSUS LOSS SEK 1.1
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr1FPRKg 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))